SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
Taiwan
· Delayed Price · Currency is TWD 102.50
0.00 (0.00%)
Apr 2, 2025, 1:30 PM CST
SYN-TECH Chem. & Pharm. Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,258 | 1,115 | 986.3 | 893.23 | 983.79 | Upgrade
|
| Revenue Growth (YoY) | 12.83% | 13.02% | 10.42% | -9.21% | 3.95% | Upgrade
|
| Cost of Revenue | 770.72 | 705.17 | 618.3 | 601.88 | 612.88 | Upgrade
|
| Gross Profit | 486.94 | 409.52 | 368 | 291.35 | 370.91 | Upgrade
|
| Selling, General & Admin | 93.45 | 89.73 | 89.91 | 86.29 | 81.92 | Upgrade
|
| Research & Development | 42.51 | 37.91 | 39.86 | 36.48 | 26.62 | Upgrade
|
| Operating Expenses | 136.14 | 127.67 | 129.77 | 122.77 | 108.54 | Upgrade
|
| Operating Income | 350.8 | 281.85 | 238.23 | 168.59 | 262.37 | Upgrade
|
| Interest Expense | -2.14 | -5.74 | -5.92 | -3.39 | -3.5 | Upgrade
|
| Interest & Investment Income | 20.31 | 29.73 | 16.01 | 2.26 | 6.22 | Upgrade
|
| Earnings From Equity Investments | - | 0.7 | -11.59 | -0.73 | -3.19 | Upgrade
|
| Currency Exchange Gain (Loss) | 42.97 | 2.57 | 89.96 | -18.79 | -31.27 | Upgrade
|
| Other Non Operating Income (Expenses) | 7.35 | 5.42 | 34.99 | 119.22 | 1.29 | Upgrade
|
| EBT Excluding Unusual Items | 419.29 | 314.53 | 361.68 | 267.15 | 231.92 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.78 | - | -6.15 | - | 0.99 | Upgrade
|
| Gain (Loss) on Sale of Assets | -5.48 | -0.77 | -0.3 | -0.73 | - | Upgrade
|
| Other Unusual Items | - | - | - | -237.39 | - | Upgrade
|
| Pretax Income | 488.24 | 313.77 | 355.24 | 200.23 | 232.91 | Upgrade
|
| Income Tax Expense | 94.95 | 62.76 | 59.95 | 23.07 | 46.17 | Upgrade
|
| Net Income | 393.28 | 251.01 | 295.29 | 177.16 | 186.74 | Upgrade
|
| Net Income to Common | 393.28 | 251.01 | 295.29 | 177.16 | 186.74 | Upgrade
|
| Net Income Growth | 56.68% | -14.99% | 66.68% | -5.13% | 17.10% | Upgrade
|
| Shares Outstanding (Basic) | 45 | 45 | 45 | 35 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 45 | 45 | 45 | 35 | 30 | Upgrade
|
| Shares Change (YoY) | 0.03% | 0.05% | 26.57% | 17.18% | 0.07% | Upgrade
|
| EPS (Basic) | 8.82 | 5.63 | 6.62 | 5.03 | 6.21 | Upgrade
|
| EPS (Diluted) | 8.80 | 5.62 | 6.61 | 5.02 | 6.20 | Upgrade
|
| EPS Growth | 56.58% | -14.98% | 31.67% | -19.03% | 16.98% | Upgrade
|
| Free Cash Flow | 408.92 | -175.05 | -38.59 | 24.93 | 257.63 | Upgrade
|
| Free Cash Flow Per Share | 9.15 | -3.92 | -0.86 | 0.71 | 8.56 | Upgrade
|
| Dividend Per Share | 5.300 | 3.500 | 3.000 | 2.150 | 4.000 | Upgrade
|
| Dividend Growth | 51.43% | 16.67% | 39.53% | -46.25% | 14.29% | Upgrade
|
| Gross Margin | 38.72% | 36.74% | 37.31% | 32.62% | 37.70% | Upgrade
|
| Operating Margin | 27.89% | 25.29% | 24.15% | 18.87% | 26.67% | Upgrade
|
| Profit Margin | 31.27% | 22.52% | 29.94% | 19.83% | 18.98% | Upgrade
|
| Free Cash Flow Margin | 32.51% | -15.70% | -3.91% | 2.79% | 26.19% | Upgrade
|
| EBITDA | 491.55 | 390.36 | 316.24 | 237.6 | 330.7 | Upgrade
|
| EBITDA Margin | 39.09% | 35.02% | 32.06% | 26.60% | 33.62% | Upgrade
|
| D&A For EBITDA | 140.75 | 108.51 | 78.01 | 69.01 | 68.33 | Upgrade
|
| EBIT | 350.8 | 281.85 | 238.23 | 168.59 | 262.37 | Upgrade
|
| EBIT Margin | 27.89% | 25.29% | 24.15% | 18.87% | 26.67% | Upgrade
|
| Effective Tax Rate | 19.45% | 20.00% | 16.88% | 11.52% | 19.82% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.